| Aug 11 |
OptiNose, Inc. (OPTN) Q2 2024 Earnings Call Transcript
|
| Aug 10 |
OptiNose Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
| Aug 8 |
OptiNose (OPTN) Reports Q2 Loss, Lags Revenue Estimates
|
| Aug 8 |
OptiNose: Q2 Earnings Snapshot
|
| Aug 8 |
OptiNose GAAP EPS of -$0.05 beats by $0.03, revenue of $20.49M misses by $0.59M
|
| Aug 8 |
Optinose Reports Second Quarter 2024 Financial Results and Recent Operational Highlights
|
| Aug 2 |
Optinose Announces Reporting Date for Second Quarter 2024 Financial Results
|
| Jul 17 |
Profound Medical (PROF) Surges 6.0%: Is This an Indication of Further Gains?
|
| Jul 2 |
7 Little-Known Penny Stocks That Can Turn $10K Into $1 Million
|
| Jun 27 |
Expanded Access to XHANCE with Addition to National Commercial Formularies
|
